ATE547395T1 - Aminopropanol-derivate als modulatoren des sphingosin-1-phosphat-rezeptors - Google Patents
Aminopropanol-derivate als modulatoren des sphingosin-1-phosphat-rezeptorsInfo
- Publication number
- ATE547395T1 ATE547395T1 AT04730206T AT04730206T ATE547395T1 AT E547395 T1 ATE547395 T1 AT E547395T1 AT 04730206 T AT04730206 T AT 04730206T AT 04730206 T AT04730206 T AT 04730206T AT E547395 T1 ATE547395 T1 AT E547395T1
- Authority
- AT
- Austria
- Prior art keywords
- sphingosine
- modulators
- phosphate receptor
- aminopropanol derivatives
- aminopropanol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
- C07C217/66—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
- C07C217/72—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/094—Esters of phosphoric acids with arylalkanols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0309944 | 2003-04-30 | ||
GB0329505A GB0329505D0 (en) | 2003-12-19 | 2003-12-19 | Organic compounds |
GB0329500A GB0329500D0 (en) | 2003-12-19 | 2003-12-19 | Organic compounds |
PCT/EP2004/004569 WO2004096752A1 (en) | 2003-04-30 | 2004-04-29 | Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE547395T1 true ATE547395T1 (de) | 2012-03-15 |
Family
ID=33424535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04730206T ATE547395T1 (de) | 2003-04-30 | 2004-04-29 | Aminopropanol-derivate als modulatoren des sphingosin-1-phosphat-rezeptors |
Country Status (11)
Country | Link |
---|---|
US (1) | US7625950B2 (de) |
EP (1) | EP1622860B1 (de) |
JP (1) | JP4603531B2 (de) |
CN (1) | CN1777575B (de) |
AT (1) | ATE547395T1 (de) |
AU (1) | AU2004234066B2 (de) |
BR (1) | BRPI0410025A (de) |
CA (1) | CA2523582A1 (de) |
ES (1) | ES2383298T3 (de) |
MX (1) | MXPA05011596A (de) |
WO (1) | WO2004096752A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1546110A4 (de) | 2002-07-30 | 2008-03-26 | Univ Virginia | Verbindungen mit wirkung bei der signalübertragung mittels sphingosin-1-phosphat |
ES2383298T3 (es) * | 2003-04-30 | 2012-06-20 | Novartis Ag | Derivados del amino-propanol como moduladores del receptor esfingosina-1-fosfato |
GB0313612D0 (en) * | 2003-06-12 | 2003-07-16 | Novartis Ag | Organic compounds |
WO2005021503A1 (en) | 2003-08-28 | 2005-03-10 | Novartis Ag | Aminopropanol derivatives |
US7638637B2 (en) | 2003-11-03 | 2009-12-29 | University Of Virginia Patent Foundation | Orally available sphingosine 1-phosphate receptor agonists and antagonists |
GB0329498D0 (en) * | 2003-12-19 | 2004-01-28 | Novartis Ag | Organic compounds |
EP1760071A4 (de) | 2004-06-23 | 2008-03-05 | Ono Pharmaceutical Co | Verbindung mit s1p-rezeptorbindungsfähigkeit und verwendung dafür |
PL1772145T3 (pl) * | 2004-07-16 | 2011-08-31 | Kyorin Seiyaku Kk | Sposób skutecznego stosowania leku i sposób dotyczący zapobiegania efektom ubocznym |
WO2006020951A1 (en) | 2004-08-13 | 2006-02-23 | Praecis Pharmaceuticals, Inc. | Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
KR101181090B1 (ko) | 2004-10-12 | 2012-09-07 | 교린 세이야꾸 가부시키 가이샤 | 2-아미노-2-[2-[4-(3-벤질옥시페닐티오)-2-클로로페닐]에틸]-1,3-프로판디올 염산염 또는 그 수화물의 제조방법 및 그 제조 중간체 |
MX2007009848A (es) | 2005-02-14 | 2008-03-10 | Univ Virginia | Agonistas de esfingosina 1-fosfato comprendiendo cicloalcanos y heterociclos de 5 miembros substituidos por grupos amino y fenilo. |
GB0513431D0 (en) | 2005-06-30 | 2005-08-10 | Kherion Technology Ltd | Prophylactic compositions and uses |
PT1932522E (pt) * | 2005-10-07 | 2012-06-26 | Kyorin Seiyaku Kk | Agente terapêutico para doenças do fígado contendo, como princípio activo, um derivado de 2- amino-1,3-propanodiol |
PL1961734T3 (pl) | 2005-12-15 | 2012-02-29 | Mitsubishi Tanabe Pharma Corp | Związek aminowy i jego zastosowanie do celów medycznych |
RU2008134702A (ru) | 2006-01-27 | 2010-03-10 | Юниверсити Оф Вирждиния Пэтент Фаундейшн (Us) | Способ лечения невропатической боли |
TWI389683B (zh) * | 2006-02-06 | 2013-03-21 | Kyorin Seiyaku Kk | A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient |
CA2641718A1 (en) | 2006-02-09 | 2007-08-16 | University Of Virginia Patent Foundation | Bicyclic sphingosine 1-phosphate analogs |
US8097644B2 (en) | 2006-03-28 | 2012-01-17 | Allergan, Inc. | Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist |
MY146775A (en) | 2006-08-08 | 2012-09-28 | Kyorin Seiyaku Kk | Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
NZ574011A (en) | 2006-08-08 | 2011-10-28 | Kyorin Seiyaku Kk | Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
CA2669102A1 (en) | 2006-11-21 | 2008-05-29 | University Of Virginia Patent Foundation | Tetralin analogs having sphingosine 1-phosphate agonist activity |
AU2007323540A1 (en) | 2006-11-21 | 2008-05-29 | University Of Virginia Patent Foundation | Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity |
JP2010510251A (ja) | 2006-11-21 | 2010-04-02 | ユニバーシティ オブ バージニア パテント ファンデーション | スフィンゴシン=1−燐酸受容体活性を有するベンゾシクロヘプチルアナログ |
US8524917B2 (en) | 2007-01-11 | 2013-09-03 | Allergan, Inc. | 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity |
CA2690686C (en) * | 2007-06-14 | 2013-08-06 | Mitsubishi Tanabe Pharma Corporation | Amine compound and pharmaceutical use thereof |
US7888336B2 (en) | 2007-09-24 | 2011-02-15 | Allergan, Inc. | Indole compounds bearing aryl or heteroaryl groups having sphingosine 1-phosphate (S1P) receptor biological activity |
TW200946105A (en) | 2008-02-07 | 2009-11-16 | Kyorin Seiyaku Kk | Therapeutic agent or preventive agent for inflammatory bowel disease containing amino alcohol derivative as active ingredient |
KR20110025751A (ko) | 2008-05-08 | 2011-03-11 | 알러간, 인코포레이티드 | 치료적으로 유용한 치환된 1,7-다이페닐-1,2,3,5,6,7-헥사하이드로피리도[3,2,1-ij]퀴놀린 화합물 |
US8143291B2 (en) | 2008-05-09 | 2012-03-27 | Allergan, Inc. | Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity |
HUE030424T2 (en) | 2008-07-23 | 2017-05-29 | Arena Pharm Inc | Substituted 1,2,3,4-tetrahydrocyclopenta [b] indol-3-ylacetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
SI2342205T1 (sl) | 2008-08-27 | 2016-09-30 | Arena Pharmaceuticals, Inc. | Substituirani triciklični kislinski derivati kot agonisti S1P1 receptorja, uporabni v zdravljenju avtoimunskih in vnetnih obolenj |
CN102686574A (zh) * | 2009-10-23 | 2012-09-19 | 阿勒根公司 | 作为具有治疗应用的受体调节剂的香豆素化合物 |
CA2780859A1 (en) * | 2009-12-10 | 2011-06-16 | Novartis Ag | Fty720 halogenated derivatives |
ES2937386T3 (es) | 2010-01-27 | 2023-03-28 | Arena Pharm Inc | Procesos para la preparación de ácido (R)-2-(7-(4-ciclopentil-3-(trifluorometil)benciloxi)-1,2,3,4-tetrahidrociclopenta[b]indol-3-il)acético y sales del mismo |
WO2011109471A1 (en) | 2010-03-03 | 2011-09-09 | Arena Pharmaceuticals, Inc. | Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
CN102260178A (zh) * | 2010-05-25 | 2011-11-30 | 中国医学科学院药物研究所 | 羟基丙二醇类衍生物、其制备方法和其药物组合物与用途 |
EP3242666A1 (de) | 2015-01-06 | 2017-11-15 | Arena Pharmaceuticals, Inc. | Verfahren zur behandlung von erkrankungen im zusammenhang mit dem s1p1-rezeptor |
JP6838744B2 (ja) | 2015-06-22 | 2021-03-03 | アリーナ ファーマシューティカルズ, インコーポレイテッド | S1P1レセプター関連障害における使用のための(R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸(化合物1)の結晶性L−アルギニン塩 |
KR20190116416A (ko) | 2017-02-16 | 2019-10-14 | 아레나 파마슈티칼스, 인크. | 원발 담즙성 담관염을 치료하기 위한 화합물 및 방법 |
CN110545848A (zh) | 2017-02-16 | 2019-12-06 | 艾尼纳制药公司 | 用于治疗具有肠外表现的炎症性肠病的化合物和方法 |
WO2020051378A1 (en) | 2018-09-06 | 2020-03-12 | Arena Pharmaceuticals, Inc. | Compounds useful in the treatment of autoimmune and inflammatory disorders |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT778263E (pt) * | 1994-08-22 | 2002-06-28 | Mitsubishi Pharma Corp | Composto de benzeno e sua utilizacao farmaceutica |
GB2309868A (en) * | 1996-01-30 | 1997-08-06 | Sony Corp | Radio receiver detects FCCH synchronising signal |
ATE298740T1 (de) * | 1997-04-04 | 2005-07-15 | Mitsubishi Pharma Corp | 2-aminopropan-1,3-diol-verbindungen, ihre medizinische anwendung und zwischenprodukte zu ihrer synthese |
DE69830751T2 (de) | 1997-04-10 | 2006-05-18 | Pharmacia & Upjohn Co. Llc, Kalamazoo | Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen |
ATE314383T1 (de) * | 2001-03-26 | 2006-01-15 | Novartis Pharma Gmbh | 2-amino-propanol derivate |
JP2002316985A (ja) * | 2001-04-20 | 2002-10-31 | Sankyo Co Ltd | ベンゾチオフェン誘導体 |
JP4152884B2 (ja) * | 2001-09-27 | 2008-09-17 | 杏林製薬株式会社 | ジアリールエーテル誘導体とその付加塩及び免疫抑制剤 |
MXPA04002679A (es) * | 2001-09-27 | 2004-07-30 | Kyorin Seiyaku Kk | Derivados de sulfuro de diarilo, sales de los mismos y agentes inmunosupresores que utilizan los mismos. |
CA2497067A1 (en) * | 2002-09-13 | 2004-03-25 | Novartis Ag | Amino-propanol derivatives |
ES2383298T3 (es) * | 2003-04-30 | 2012-06-20 | Novartis Ag | Derivados del amino-propanol como moduladores del receptor esfingosina-1-fosfato |
-
2004
- 2004-04-29 ES ES04730206T patent/ES2383298T3/es not_active Expired - Lifetime
- 2004-04-29 US US10/554,556 patent/US7625950B2/en not_active Expired - Fee Related
- 2004-04-29 BR BRPI0410025-5A patent/BRPI0410025A/pt not_active IP Right Cessation
- 2004-04-29 CN CN2004800110595A patent/CN1777575B/zh not_active Expired - Fee Related
- 2004-04-29 MX MXPA05011596A patent/MXPA05011596A/es active IP Right Grant
- 2004-04-29 AT AT04730206T patent/ATE547395T1/de active
- 2004-04-29 JP JP2006505327A patent/JP4603531B2/ja not_active Expired - Fee Related
- 2004-04-29 CA CA002523582A patent/CA2523582A1/en not_active Abandoned
- 2004-04-29 WO PCT/EP2004/004569 patent/WO2004096752A1/en active Search and Examination
- 2004-04-29 AU AU2004234066A patent/AU2004234066B2/en not_active Ceased
- 2004-04-29 EP EP04730206A patent/EP1622860B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20060211658A1 (en) | 2006-09-21 |
JP4603531B2 (ja) | 2010-12-22 |
AU2004234066A1 (en) | 2004-11-11 |
JP2006524660A (ja) | 2006-11-02 |
CN1777575A (zh) | 2006-05-24 |
BRPI0410025A (pt) | 2006-04-25 |
CA2523582A1 (en) | 2004-11-11 |
MXPA05011596A (es) | 2006-01-23 |
AU2004234066B2 (en) | 2008-02-21 |
CN1777575B (zh) | 2010-05-12 |
US7625950B2 (en) | 2009-12-01 |
WO2004096752A1 (en) | 2004-11-11 |
EP1622860A1 (de) | 2006-02-08 |
ES2383298T3 (es) | 2012-06-20 |
EP1622860B1 (de) | 2012-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE547395T1 (de) | Aminopropanol-derivate als modulatoren des sphingosin-1-phosphat-rezeptors | |
MXPA05011597A (es) | Derivados de aminopropanol como moduladores del receptor 1-fosfato de esfingosina. | |
SE0202133D0 (sv) | Novel compounds | |
TW200617009A (en) | Organic compounds | |
ES2335410T8 (es) | Derivados de aminopropanol. | |
IL185275A0 (en) | N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same | |
TW200626579A (en) | Inhibitors of the interaction between MDM2 and p53 | |
TW200635921A (en) | Organic compounds | |
ATE470665T1 (de) | Cycloalkylaminderivate als inhibitoren der wechselwirkung zwischen mdm2 und p53 | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
ES2368594T3 (es) | Derivados sustituidos de ciclohexilmetilo. | |
ATE542799T1 (de) | Chinolinonderivate als parp und tank-inhibitoren | |
TW200740781A (en) | Novel compounds | |
TW200833670A (en) | Novel compounds 569 | |
BRPI0511610A (pt) | derivados de amino-propanol | |
MXPA05013348A (es) | Derivados de amino-propanol como moduladores del receptor de esfingosina-1-fosfato. | |
ATE472529T1 (de) | Prolinamidderivate als natriumkanalmodulatoren | |
ATE541839T1 (de) | Pyrrolidiniumderivate als m3-muskarinische rezeptoren | |
MX2010009022A (es) | Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso. | |
BRPI0519292A2 (pt) | compostos orgÂnicos | |
SE0303541D0 (sv) | New compounds | |
NO20062900L (no) | Nye forbindelser | |
SE0400850D0 (sv) | Novel Compounds | |
ATE450262T1 (de) | Harnstoff-derivate als calcium-rezeptor- modulatoren | |
SE0403085D0 (sv) | Novel componds |